Incidence of cardiovascular (CV)-related hospitalizations and associated costs among US patients with chronic-phase chronic myeloid leukemia (CP-CML) treated with first-line (1L) tyrosine kinase inhibitors (TKI) in SIMPLICITY: An observational study Meeting Abstract
| Authors: | Goldberg, S. L.; Mauro, M.; Cortes, J.; Keating, S. J.; Bhandari, H.; Chen, C. |
| Abstract Title: | Incidence of cardiovascular (CV)-related hospitalizations and associated costs among US patients with chronic-phase chronic myeloid leukemia (CP-CML) treated with first-line (1L) tyrosine kinase inhibitors (TKI) in SIMPLICITY: An observational study |
| Meeting Title: | 8th Annual Meeting of the Society of Hematologic Oncology (SOHO) |
| Keywords: | imatinib; cml; dasatinib; chronic myeloid leukemia; nilotinib; cost; cardiovascular |
| Journal Title: | Clinical Lymphoma, Myeloma and Leukemia |
| Volume: | 20 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2020 Sep 9-12 |
| Meeting Location: | Houston, TX |
| ISSN: | 2152-2650 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2020-09-01 |
| Start Page: | S241 |
| End Page: | S242 |
| Language: | English |
| ACCESSION: | WOS:000564055100202 |
| PROVIDER: | wos |
| DOI: | 10.1016/S2152-2650(20)30829-6 |
| Notes: | Meeting Abstract: CML-330 -- Due to COVID-19 pandemic, the conference was held virtually -- Source: Wos |
